A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

about

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

Item

http://www.wikidata.org/entity/Q58699181

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@en

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@nl

type

Item

label

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@en

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@nl

prefLabel

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@en

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@nl

P1476

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

@en

P2093

Atsushi Yamasaki

http://www.w3.org/2001/XMLSchema#string

Daniel V Santi

http://www.w3.org/2001/XMLSchema#string

Gary W Ashley

http://www.w3.org/2001/XMLSchema#string

Koichi Nakamura

http://www.w3.org/2001/XMLSchema#string

Kyosuke Tanaka

http://www.w3.org/2001/XMLSchema#string

Nobuo Machinaga

http://www.w3.org/2001/XMLSchema#string

Ralph Reid

http://www.w3.org/2001/XMLSchema#string

Yasushi Yoshigae

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Yabe

http://www.w3.org/2001/XMLSchema#string

P2860

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.

Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data.

Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates.

Ophthalmic drug discovery.

Complement factor D in age-related macular degeneration

Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.

Intraocular pharmacokinetics of intravitreal vascular endothelial growth factor-Trap in a rabbit model.

Pegaptanib in the treatment of wet, age-related macular degeneration.

Targeting the complement system for the management of retinal inflammatory and degenerative diseases.

Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/TVST.7.4.21

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30174998

http://www.w3.org/2001/XMLSchema#string

P932

6114027

http://www.w3.org/2001/XMLSchema#string